Insider filing · PTCT
Michael Schmertzler
Director
profile →
PTC Therapeutics, Inc.
PTCT · Healthcare · 80 filings in 24 months
ticker →
Michael Schmertzler sold $1.8M of PTC Therapeutics (PTCT)
Executed Aug 26, disclosed Aug 28, 2 days later.
Value, as filed
$1.8M
24,390 sh across 3 lots
Executed
Aug 26
the trade date, as filed
Disclosed
Aug 28
2 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
–
purchases only
Returns are measured on stock purchases only.
The filer
MSMichael Schmertzler (Director) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in PTC Therapeutics, Inc. (PTCT). The largest single filing was $1.8M of PTCT (24,390 sh across 3 lots, as filed), executed Aug 26.
The name
PTCTHealthcare · PTC Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of medicines to children…
More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→Other filings by Michael Schmertzler in PTCT
PTCTSALE
PTC Therapeutics, Inc.
$1.3M19,624 sh across 3 lots
Exec Sep 16
Filed Sep 18 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $1.3M
19,428 sh across 2 lots
Exec Sep 9
Filed Sep 11 · 5:20 PM ET PTCTSALE PTC Therapeutics, Inc. $1.8M
24,309 sh across 4 lots
Exec Aug 19
Filed Aug 21 · 5:20 PM ET